AngioDynamics
ANGO
150 hedge funds and large institutions have $294M invested in AngioDynamics in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 54 reducing their positions, and 33 closing their positions.
14% more capital invested
Capital invested by funds: $259M → $294M (+$35.5M)
5.15% more ownership
Funds ownership: 89.21% → 94.36% (+5.1%)
9% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 54
3% less funds holding
Funds holding: 154 → 150 (-4)
12% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 33
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$15.4M |
| 2 |
BlackRock
New York
|
+$6.12M |
| 3 |
AC
Armistice Capital
New York
|
+$5.55M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.78M |
| 5 |
F1I
Fund 1 Investments
Rincon,
Puerto Rico
|
+$3.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.98M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$4.31M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$3.47M |
| 4 |
Goldman Sachs
New York
|
-$2.75M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.24M |
ANGO Hedge Fund Activity: Q4 2023 in Review
150 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2023, worth a combined $294M — up 14% from $259M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of ANGO and 29 opened new positions — a net loss of 4 holders — while 54 trimmed existing stakes and 49 added.
The largest buyer was Morgan Stanley, adding an estimated $15.4M. The largest seller was Millennium Management, cutting an estimated $5.98M.
- 150 institutional investors held AngioDynamics (ANGO) as of Q4 2023, down from 154 in Q3 2023.
- Funds reported $294M of AngioDynamics stock for Q4 2023, up 14% quarter-over-quarter.
- 29 funds opened new AngioDynamics positions in Q4 2023 and 33 closed out, a net change of -4 holders.
- The largest AngioDynamics buyer in Q4 2023 was Morgan Stanley, an estimated $15.4M added.
- The largest AngioDynamics seller in Q4 2023 was Millennium Management, an estimated $5.98M sold.
Based on aggregated 13F filings for Q4 2023.